Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

The phase 2 randomized trial of bardoxolone methyl in patients with stage 4 chronic kidney disease and type 2 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bardoxolone Methyl (bardoxolone methyl)

Snippet

Sponsor: Biogen | Conditions: Renal Insufficiency, Chronic, Diabetes Mellitus, Type 2 | Phase 2 | Status: WITHDRAWN